WIN 2015: Oncologists and industry working together for personalised medicine

Comment: Metastatic triple-negative breast cancer responds to immunotherapy

Real-world targeted treatment based on whole genome sequencing difficult in pancreatic cancer

PARP inhibitor combo shows early promise for patients with and without BRCA mutations

Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma

Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive breast cancer

Incidences of liver cancer rising in the USA

Black women found to have denser breast tissue than white women

New data shows that generic drivers are found in benign conditions

How will genomics be applied to patient therapy in future?

Inside cancer - public lecture

Pembrolizumab showed clinical benefit in malignant pleural mesothelioma